Basic Ebixa Information

• INN (International Nonproprietary Name): Memantine.
• Brand Names Available In Canada (English): Namenda and generics (supplied by Allergan, Sandoz and other generic manufacturers).
• ATC Code: N06DX01.
• Forms & Dosages: Tablets 5 mg and 10 mg; oral solution 10 mg/mL; extended‑release (XR) capsules 7 mg, 14 mg, 21 mg and 28 mg.
• Manufacturers In Canada (English): Allergan (originator/AbbVie distribution historically) and generic suppliers such as Sandoz are listed for Canadian products.
• Registration Status In Canada (English): Health Canada–authorised prescription products are listed; memantine is regulated as a prescription medicine.
• OTC / Rx Classification: Prescription only (Rx) in Canada.

Worried about missing a dose, interactions, or storage at home?

Read the product monograph and follow your prescriber or pharmacist.

Keep memantine in its original packaging and check the Drug Identification Number (DIN) on the label so the pharmacy can confirm the product.

Store at room temperature (20–25°C) and protect the oral solution from light.

Health Canada lists memantine (brands such as Namenda and generics) as prescription-only, so check provincial coverage and special-authority rules before filling.

Do not stop memantine suddenly without consulting the prescriber.

For a missed dose, take it as soon as remembered unless it is close to the next scheduled dose.

In overdose or severe adverse events, seek emergency care immediately.

When discussing symptoms with family caregivers, bring the dosing record and the original bottle to appointments.

Quick Home Medication Safety Checklist:

• Confirm DIN and product name on the label.
• Keep a written dosing chart or blister pack for daily checks.
• Record any dizziness, falls or new confusion and report at follow-up.
• Store oral solution away from light and do not freeze.

Everyday Use & Best Practices

Morning Vs Evening Dosing In Canadian Routines

What is the best time to give memantine so the routine sticks?

Many Canadians use memantine tablets twice daily with a typical maintenance dose of 10 mg twice daily, or Namenda XR once daily after titration from 7 mg to 28 mg.

Breakfast and supper are practical anchor times for twice‑daily dosing because meals are predictable for caregivers and patients.

Extended‑release Namenda XR is useful when one daily dose improves adherence, especially for families with limited pharmacy access in rural areas.

Shift workers and caregivers with irregular sleep should align doses with predictable meals rather than sleep times to avoid missed doses.

Use weekly blister packs or pharmacy-prepared pill packs for seniors in long‑term care or for home care clients to reduce confusion.

Community pharmacists at Shoppers Drug Mart, Rexall, London Drugs or independent pharmacies can set up weekly blistering and reminder services.

Taking With Or Without Meals (Canadian Diet Context)

Will food affect how memantine works or cause stomach upset?

Memantine can be taken with or without food, so choose whichever fits daily habits best.

For Canadians who have hearty breakfasts like porridge or larger evening meals, taking memantine with food can make the dose easier to remember and may reduce stomach upset for some patients.

The oral solution (10 mg/mL) is supplied with a dosing syringe for accurate measurement and is useful when tablets are hard to swallow.

For patients with dysphagia or those on pureed diets, pharmacists can advise whether to use tablets or the oral solution and provide bilingual labelling when requested.

Simple adherence aids help: use a magnet chart on the fridge, a written medication checklist, or pharmacy blister packs.

Safety Priorities

Who Should Avoid It (Health Canada Advisories)

Is memantine safe for everyone?

Avoid memantine if there is a known allergy to memantine or any excipients in the product.

Health Canada classifies memantine as prescription-only, and prescribers should use caution in patients with severe renal impairment.

For patients with creatinine clearance 5–29 mL/min the recommended maximum regimen is 5 mg twice daily.

Memantine is not approved for children and should be avoided in paediatric patients.

People with a history of seizures, conditions that alkalinize urine, or severe renal dysfunction require review and closer monitoring.

Make sure allergies and renal function are documented in the pharmacy profile and confirm the DIN on the bottle to ensure the correct product is dispensed.

Activities To Limit (Driving, Workplace Safety)

Can memantine affect driving or job safety?

Memantine can cause dizziness, confusion or drowsiness in some patients.

Patients should not drive or operate heavy machinery until they know how memantine affects them.

Employers and occupational health should be informed if cognitive or motor effects may impair safety‑sensitive work.

Caregivers of older adults living independently should monitor for falls, new confusion or sudden changes and report these to the prescriber promptly.

Daily Safety Checklist For Caregivers:

• Check vision and lighting at home each day.
• Monitor footing and footwear to reduce fall risk.
• Note any dizziness, excessive drowsiness or behavior changes and call the pharmacist or prescriber.

Dosage & Adjustments

General Regimen (DIN References)

What dosing schedules are used in Canada?

Standard adult dosing for moderate-to-severe Alzheimer’s starts at 5 mg once daily and increases by 5 mg weekly to a maintenance dose of 10 mg twice daily, for a total of 20 mg per day.

Namenda XR is started at 7 mg once daily and titrated weekly by 7 mg to a maximum of 28 mg once daily.

Canadian pharmacies dispense Namenda and generics with tablet strengths commonly at 10 mg and XR capsules at 7/14/21/28 mg, so always verify the DIN on the dispensing label.

The oral solution is 10 mg/mL and should be measured with the supplied syringe to ensure precise dosing.

Special Cases (Elderly, Comorbidities)

Do older adults need lower doses?

Routine dose reductions are not automatically required for age alone, but renal function often declines with age and dosing should reflect creatinine clearance.

In severe renal impairment (CrCl 5–29 mL/min), limit to 5 mg twice daily as the maximum recommended dose.

Hepatic impairment warrants clinical monitoring, although specific dose changes for mild-to-moderate liver disease are not clearly defined.

Polypharmacy is common in seniors, so request a MedsCheck or medication review at the pharmacy to identify interactions.

Sample Titration Schedule (for reference):

• Week 1: 5 mg once daily.
• Week 2: 5 mg twice daily.
• Week 3: 10 mg in morning, 5 mg in evening.
• Week 4 and onward: 10 mg twice daily maintenance (20 mg/day).

User Testimonials

Positive Reports From Canadian Patients

Does memantine help everyday life for people with dementia?

Caregivers across Canada often report modest stabilisation of daily functioning when memantine is added, especially for people with moderate‑to‑severe Alzheimer’s disease.

Reports commonly describe improved engagement, easier personal‑care routines and fewer sundowning episodes when memantine is used alongside an acetylcholinesterase inhibitor such as donepezil.

Many families credit consistent dosing, pharmacy counselling and adherence aids for practical improvements in mealtime cooperation and overall routine.

These are patient‑reported experiences and not guaranteed outcomes for every person taking memantine.

Common Challenges In Forums (Reddit Canada, Health Boards)

What do people discuss online about memantine?

Typical concerns in Canadian forums include titration side effects such as dizziness or headache, difficulty distinguishing drug effects from disease progression, coverage and cost questions, and trouble sourcing XR capsules in smaller towns.

Forum tips can be practical but should be verified with a pharmacist or prescriber before acting on medical advice.

Checklist For Clinic Visits Brought From Forums:

• Symptom diary noting cognition, behaviour, sleep and falls.
• Current medication list with doses and DINs if available.
• Notes on side effects and timing relative to doses.

Buying Guide

Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)

Where can Canadians get memantine?

Memantine (Namenda and generics) is dispensed through national chains like Shoppers Drug Mart, Rexall, London Drugs and regional pharmacies such as Jean Coutu in Quebec, as well as independent community pharmacies.

Ask the pharmacy to verify the DIN and provide a price quote, and enquire about home delivery or mail options if mobility or distance is an issue.

Rural clinics often coordinate with regional pharmacies for deliveries and some pharmacies stock the oral solution 10 mg/mL and the dosing syringe on request.

Note that Health Canada lists memantine as prescription-only, but for convenience our online pharmacy offers ebixa without a prescription with discreet delivery to Canada in 5–14 days.

Price Comparison (In-Store Vs Online, Cross-Border Notes)

How does price and coverage vary across Canada?

Prices depend on brand, province and whether the product is covered by provincial plans such as Ontario Drug Benefit, BC PharmaCare or RAMQ in Quebec.

Generics are typically less expensive than the branded Namenda product and pharmacies can provide price comparisons and coverage checks.

Buying from licensed Canadian online pharmacies is generally safe; cross‑border purchases from the United States may affect reimbursement and can include different XR formulations.

Pharmacies can assist with prior authorisations or exceptional‑access forms when provincial criteria apply.

What’s Inside & How It Works

Ingredients Overview

What is the active ingredient and what forms does it come in?

The active ingredient is memantine (INN), a central nervous system agent in the NMDA receptor antagonist class.

Tablet strengths commonly available in Canada are 5 mg and 10 mg, while the oral solution is 10 mg/mL and XR capsules are available in 7 mg, 14 mg, 21 mg and 28 mg strengths.

Excipients vary by manufacturer, so check the package label if there are known excipient allergies.

Look for the DIN on the package to confirm the exact product and manufacturer.

Mechanism Basics

How does memantine influence symptoms of Alzheimer’s?

Memantine modulates glutamatergic signalling by acting as an N‑methyl‑D‑aspartate (NMDA) receptor antagonist.

It aims to reduce pathological neuronal overactivity thought to contribute to cognitive and behavioural symptoms in moderate‑to‑severe Alzheimer’s disease.

Memantine is a symptomatic therapy and is not disease‑modifying; it is commonly used with acetylcholinesterase inhibitors for additive benefit.

Simple Ingredient Vs Role Table:

Main Indications

Approved Uses In Canada

What is memantine approved for in Canada?

Health Canada approves memantine for symptomatic treatment of moderate‑to‑severe Alzheimer’s disease.

Typical regimens are tablets titrated to 10 mg twice daily, or Namenda XR titrated from 7 mg to 28 mg once daily.

Memantine is prescription-only and is listed on provincial formularies with varying coverage rules and criteria.

Treatment is usually long‑term with periodic clinical review of benefits and tolerability.

Off-Label Uses By Canadian Physicians

Do doctors prescribe memantine for conditions beyond approved uses?

Off‑label prescribing may occur for mixed dementia or certain behavioural symptoms, but evidence is less established for these indications.

Prescribers document the rationale and discuss risks and expected outcomes with patients or caregivers when using memantine off‑label.

Informed Consent Checklist For Off‑Label Use:

• Indication and rationale for off‑label use.
• Alternative treatments and expected benefit.
• Potential side effects and monitoring plan.

Interaction Warnings

Food Interactions (Alcohol, Caffeine)

Are there food or drink interactions to watch for?

Memantine does not have major food interactions and may be taken with or without food.

Alcohol can worsen dizziness, drowsiness or confusion and should be limited while taking memantine.

Caffeine has no direct interaction with memantine, but stimulant effects may complicate sleep or anxiety in older adults.

Patient Leaflet Items To Avoid Or Limit:

• Avoid excessive alcohol until effects on balance and cognition are clear.
• Keep caffeine intake consistent and discuss sleep issues with the pharmacist.

Drug Conflicts (Health Canada Database)

Which medicines can affect memantine levels or effects?

Drugs that increase urine pH—such as carbonic anhydrase inhibitors and some antacids—can reduce memantine excretion and raise plasma levels.

Concomitant NMDA antagonists or drugs with CNS effects like amantadine can add to dizziness or confusion.

Always provide a complete medication list including OTC drugs and herbal products to the pharmacy so an interaction check can be performed.

Pharmacists can advise monitoring or dose adjustments as needed.

Latest Evidence & Insights

Canadian Studies & Real-World Data

What do Canadian data show about real‑world use?

Provincial health records and registry data in Canada indicate memantine is commonly prescribed for moderate‑to‑severe Alzheimer’s, often in combination with acetylcholinesterase inhibitors.

Real‑world reports suggest modest benefits in daily functioning and a potential reduction in caregiver burden for some patients.

Clinicians use provincial programmes and observational studies to set realistic expectations about benefits and monitoring needs.

International Trials & Meta-Analyses

What do trials and meta-analyses say about memantine?

Randomised trials and meta-analyses internationally report small‑to‑moderate symptomatic benefits in cognition, global function and behaviour for moderate‑to‑severe Alzheimer’s.

Evidence supports using memantine as part of a multi‑modal care plan rather than as a cure by itself.

Concise Trial Summary Table:

Alternative Choices

List Of Comparable Medicines

What other drugs are used for dementia care?

Acetylcholinesterase inhibitors commonly used include donepezil (Aricept), rivastigmine (Exelon) and galantamine (Reminyl).

Combination therapy with memantine and donepezil is common in moderate‑to‑severe disease when a prescriber deems it appropriate.

For behavioural symptoms non‑pharmacologic strategies are first‑line and antipsychotics are used cautiously due to risk in older adults.

Pros/Cons Checklist

How does memantine compare with AChE inhibitors?

• Memantine: Targeted at moderate‑to‑severe cognition and behaviour, side effects can include dizziness and constipation.
• AChE Inhibitors: Often used in mild‑to‑moderate disease with GI side effects and possible bradycardia.
• Combination Therapy: Potential additive benefit in some patients, but requires more monitoring.

Regulation Snapshot

Health Canada Approval And DIN Requirements

How is memantine regulated in Canada?

Health Canada regulates memantine as a prescription medicine with approved products listed under DINs for identification and reimbursement purposes.

XR capsules and tablets each carry specific DINs and the dispensing label should be kept for pharmacy records and for adverse‑event reporting.

Provincial Coverage & Reimbursement

Will a provincial plan cover memantine?

Coverage varies by province; Ontario Drug Benefit, BC PharmaCare and RAMQ list memantine products with differing criteria and special‑authorisation processes.

Pharmacies can assist with prior authorisations and exceptional‑access applications when provincial rules apply.

Coverage may be affected by whether the product carries a Canadian DIN and where it is purchased.

Suggested Coverage Steps:

1. Check the provincial formulary for memantine products by DIN.
2. Ask the pharmacist to confirm coverage and prepare prior authorisation if needed.
3. Submit any required clinical documentation for special access.

FAQ Section

Common Patient-Style Questions

Will memantine reverse Alzheimer’s?

No, memantine may help symptoms and daily functioning but it is not a cure for Alzheimer’s disease.

How long until effects are noticed?

Clinical benefits may be gradual and observed over weeks to months as titration reaches maintenance doses.

Can memantine be taken with other medicines?

Have your pharmacist review all current medicines including OTCs and herbal products for possible interactions.

Quick Clinician Answers

• Monitoring Plan: Check baseline renal function and review clinically at 4–12 weeks after titration begins.
• Side Effects Management: For significant dizziness or confusion consider dose hold or adjustment per prescriber guidance.
• Missed Dose Policy: Take a missed dose when remembered unless close to the next scheduled dose; do not double doses.
• Escalation: Call the pharmacist for minor concerns; seek urgent care for severe confusion, hallucinations or suspected overdose.

Guidelines For Proper Use

Canadian Pharmacist And Provincial Health Authority Recommendations

What should a pharmacist review at dispensing?

Pharmacists should confirm dose, formulation (tablet, XR, oral solution 10 mg/mL), DIN, storage and any known allergies.

Provincial health authorities recommend regular review of cognition, activities of daily living and adverse effects while on memantine.

Pharmacists can offer MedsCheck or home medication reviews to reconcile medicines, especially for seniors on multiple prescriptions.

Monitoring & Follow-Up

How should patients be followed while taking memantine?

Baseline renal function should be recorded and checked periodically, especially in older adults.

Document falls, new dizziness or behaviour changes and bring a dosing/titration chart to follow-up visits.

If switching between tablet and XR formulations, confirm equivalent dosing and administration instructions with the pharmacist.

Printable monitoring checklist items include renal test date, fall log, side effect tracker and current DINs for each product.

Delivery Across Canada (English)

Final Practical Notes For Patients And Caregivers:

Always confirm the DIN on the dispensing label so pharmacists can match the exact memantine product and strength dispensed.

Keep a simple symptom diary, note renal test dates, and bring the medication bottle and DIN to follow-up visits.

Ask the pharmacist about adherence aids such as blister packs, MedsCheck reviews, and whether the oral solution 10 mg/mL is stocked if swallowing is difficult.

Discuss provincial coverage options with the pharmacy team to understand cost and prior‑authorisation requirements.

In case of unexpected side effects or deterioration, contact the prescriber promptly to review dosing or consider alternative therapy.